Nexome Genomics
Nexome Genomics provides cloud-based, integrated analytics solutions that empower healthcare institutions with on-demand access to precision medicine. Their technology leverages next-generation sequencing (NGS) data to improve disease diagnosis and personalize treatment strategies, supporting medical centers, hospitals, and physician offices in generating diagnostic and prognostic reports. Since 2016, based in Maryland, USA, Nexome focuses on developing advanced genomic data analytics and reporting systems to facilitate precise clinical reporting and support the growing field of personalized medicine.
Industries
Nr. of Employees
small (1-50)
Nexome Genomics
Rockville, Maryland, United States
Products
Cloud-hosted NGS data analytics and reporting platform
A platform for storage, processing, and clinical reporting of NGS datasets, providing automated analysis and report generation to institutional customers.
Targeted oncology gene panels (pan-cancer and tumor-specific)
A set of targeted NGS panels designed for oncology applications, covering pan-cancer and tumor-specific gene sets to detect mutations relevant to diagnosis and treatment.
Fluorescence in situ Hybridization
Full-service molecular cytogenetics testing, predominantly for oncology and prenatal medicine applications.
Sequencing services
Comprehensive sequencing solutions including whole genome and exome analyses, disease-specific panels, and next-generation sequencing (NGS) analytics.
Microarray and qPCR Gene Expression and mutation detection services
Advanced microarray platform testing and qPCR services for gene expression and mutation detection.
Nexome Discover
A cloud-based diagnostic and prognostic reporting system that integrates with NGS analytics.
Cloud-hosted NGS data analytics and reporting platform
A platform for storage, processing, and clinical reporting of NGS datasets, providing automated analysis and report generation to institutional customers.
Targeted oncology gene panels (pan-cancer and tumor-specific)
A set of targeted NGS panels designed for oncology applications, covering pan-cancer and tumor-specific gene sets to detect mutations relevant to diagnosis and treatment.
Fluorescence in situ Hybridization
Full-service molecular cytogenetics testing, predominantly for oncology and prenatal medicine applications.
Sequencing services
Comprehensive sequencing solutions including whole genome and exome analyses, disease-specific panels, and next-generation sequencing (NGS) analytics.
Microarray and qPCR Gene Expression and mutation detection services
Advanced microarray platform testing and qPCR services for gene expression and mutation detection.
Nexome Discover
A cloud-based diagnostic and prognostic reporting system that integrates with NGS analytics.
Services
On-demand cloud service that processes NGS data to produce diagnostic and prognostic reports for healthcare institutions.
On-demand cloud service that processes NGS data to produce diagnostic and prognostic reports for healthcare institutions.
Expertise Areas
- NGS data analysis and clinical reporting
- Oncology genomics and targeted panel development
- Bioinformatics and statistical genomics
- Genomic data storage and cloud infrastructure
Key Technologies
- Next-generation sequencing (NGS)
- Cloud-based analytics platforms
- Targeted gene panels
- Variant calling and indel analysis